Neuberger Berman Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Neuberger Berman Group's ABMD Position: Q4 2022 in Review
Neuberger Berman Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,173 shares — an estimated $1.03M sold.
Neuberger Berman Group first reported a position in ABMD in Q3 2013 and held it in 21 quarters. The position peaked at $66.6M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Neuberger Berman Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Neuberger Berman Group sold 4,173 Abiomed Inc shares in Q4 2022, an estimated $1.03M.
- Neuberger Berman Group first reported a position in Abiomed Inc in Q3 2013 and held it in 21 quarters.
- Neuberger Berman Group's Abiomed Inc position peaked at $66.6M in Q2 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Neuberger Berman Group's 13F filing for Q4 2022, filed 13 Feb 2023.